Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
GRIA2 (Glutamate ionotropic receptor AMPA type subunit 2) encodes a multi‑pass transmembrane AMPA‑class ionotropic glutamate receptor subunit predominantly localised to plasma‑membrane compartments, with minor protein fractions detected within intracellular vesicular membrane structures. This receptor subunit occurs across multiple organ‑derived tissue populations and displays distinct, tissue‑biased expression profiles, with prominent enrichment within nervous‑system‑related tissue compartments. Distinct from soluble intracellular polypeptides, it bears re‑entrant pore‑forming transmembrane segments together with large extracellular ligand‑binding domains and variable cytoplasmic terminal segments harbouring interaction motifs for downstream partner engagement. It acts as a membrane‑embedded receptor subunit, assembling with adjacent membrane‑resident partner components to form cation‑permeable molecular assemblies under physiological states. Insufficient GRIA2 protein abundance may impair normal membrane‑associated receptor‑partner complex assembly and disturb downstream cellular membrane‑adaptive behaviours. GRIA2 may exert molecular buffering functions to sustain suitable ion‑dependent molecular configurations within cell populations. Diverse cellular physiological and ligand‑responsive phases bring shifting membrane‑ion homeostasis demands, requiring varied transmembrane receptor proteins to maintain multicellular tissue physiological equilibrium. Membrane‑anchored GRIA2 assembles with partner membrane‑resident protein units to counteract abnormal receptor‑complex rearrangements and preserve stable plasma‑membrane functional states.
Sequence‑level alterations to the GRIA2 locus may compromise the structural organisation of assembled plasma‑membrane receptor‑partner complexes and alter readouts derived from cell‑surface molecular interaction events. Closely related members of AMPA‑type glutamate‑receptor subfamily cannot fully replicate the complete set of GRIA2‑dependent behaviours during heteromeric receptor‑complex formation and stable integration within plasma‑membrane assemblies. Shifts in GRIA2 protein levels often align with cellular demands for membrane‑ion‑related activities, making this protein a useful research target to explore AMPA‑class glutamate‑receptor activities and membrane‑ion‑balance molecular dynamics. Predominantly distributed at plasma‑membrane together with minor intracellular membrane fractions, GRIA2 contributes to heteromeric receptor‑complex formation and does not sustain persistent cation permeation without appropriate extracellular ligand‑derived stimulation. Its multi‑modular multi‑transmembrane AMPA‑receptor architecture with large extracellular sensing domains distinguishes this membrane glycoprotein from many other membrane‑embedded surface components; such structural features support the maintenance of membrane‑receptor complex arrangement and permit selective physical contacts with cell‑surface binding partners. Diminished functional performance of GRIA2 may disturb the proper arrangement of plasma‑membrane receptor assemblies and weaken endogenous cellular adaptive buffering capacity, further supporting its research value for studies focused on AMPA‑type ionotropic glutamate receptor subunits.
Fig. 1 Fluorescence imaging of cell-surface labeling of recombinantly expressed GRIA2 (GluA2) in HEK293T cells. This image was obtained from an overexpression-based heterologous cell system rather than native physiological conditions.¹1
The biological functions of transmembrane GRIA2 receptor protein are focused on sustained heteromeric partner-complex interaction and plasma-membrane-homeostasis coordination:
Creative Biolabs offers purified GRIA2 membrane samples produced under unified preparation workflows, including full-length GRIA2 constructs and isolated domain variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, while full-length constructs suit research focused on receptor-subunit-partner interaction and plasma-membrane anchoring functional observation. All batches receive uniform quality screening. Functional-relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length GRIA2 samples retain intact partner-interaction-domain conformation after standardized purification, which supports reliable detection of weak and transient subunit-partner contacts for comparative functional analysis.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable GRIA2 expression cell research models with varied expression levels, applicable to structural observation of multi-pass transmembrane AMPA-class glutamate-receptor proteins and research into membrane-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of subunit-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-GRIA2 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of subunit-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for GRIA2 research:
GRIA2 might act as a multi-pass transmembrane AMPA-class glutamate-receptor subunit protein and participate in heteromeric plasma-membrane complex assembly to modulate membrane-receptor-complex arrangement and plasma-membrane homeostasis.
GRIA2 expression status could alter membrane-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as a major receptor mediator of membrane-ion-homeostasis-associated biological processes.
No, GRIA2-associated research reagents from Creative Biolabs are exclusively built for exploring membrane-receptor-dependent plasma-membrane ion-regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length GRIA2 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on plasma-membrane homeostasis and membrane-receptor-mediated membrane-partner perception.
Laboratory observation schemes may include subunit-partner interaction related tests to analyse molecular-binding associated behaviors under simulated plasma-membrane environments.
